Unit of Molecular Medicine for Neuromuscular and Neurodegenerative Diseases

Rome, Italy

Unit of Molecular Medicine for Neuromuscular and Neurodegenerative Diseases

Rome, Italy
SEARCH FILTERS
Time filter
Source Type

Nogueira C.,National Institute of Health | Barros J.,Hospital Santo Antonio | Barros J.,Abel Salazar Biomedical Sciences Institute | Sa M.J.,Hospital Sao Joao | And 13 more authors.
Neurogenetics | Year: 2013

Complex III of the mitochondrial respiratory chain (CIII) catalyzes transfer of electrons from reduced coenzyme Q to cytochrome c. Low biochemical activity of CIII is not a frequent etiology in disorders of oxidative metabolism and is genetically heterogeneous. Recently, mutations in the human tetratricopeptide 19 gene (TTC19) have been involved in the etiology of CIII deficiency through impaired assembly of the holocomplex. We investigated a consanguineous Portuguese family where four siblings had reduced enzymatic activity of CIII in muscle and harbored a novel homozygous mutation in TTC19. The clinical phenotype in the four sibs was consistent with severe olivo-ponto-cerebellar atrophy, although their age at onset differed slightly. Interestingly, three patients also presented progressive psychosis. The mutation resulted in almost complete absence of TTC19 protein, defective assembly of CIII in muscle, and enhanced production of reactive oxygen species in cultured skin fibroblasts. Our findings add to the array of mutations in TTC19, corroborate the notion of genotype/phenotype variability in mitochondrial encephalomyopathies even within a single family, and indicate that psychiatric manifestations are a further presentation of low CIII. © 2013 Springer-Verlag Berlin Heidelberg.

Loading Unit of Molecular Medicine for Neuromuscular and Neurodegenerative Diseases collaborators
Loading Unit of Molecular Medicine for Neuromuscular and Neurodegenerative Diseases collaborators